Here, we explored the differentially expressed genes (DEGs) generated by comparing immune components and stromal components in PAAD samples and revealed that CXCL10 might be a potential indicator for the alteration of TME status in PAAD. The gene discussed is CXCL10; the disease is pancreatic adenocarcinoma.